Novel genomic rearrangements in the BRCA1 gene detected in greek breast/ovarian cancer patients

European Journal of Cancer

Volumn 43, Issue 2, 2007, Pages 443-453

  Armaou, Sophia ^a   Konstantopoulou, Irene ^b   Anagnostopoulos, Theodore ^a   Razis, Evangelia ^c   Boukovinas, Ioannis ^d   Xenidis, Nikolaos ^d   Fountzilas, George ^e,f   Yannoukakos, Drakoulis ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b Biogenomica   (Greece)

^c HYGEIA HOSPITAL   (Greece)

^d Theageneio Cancer Hospital   (Greece)

^e PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^f Hellenic Cooperative Oncology Group   (Greece)

Author keywords

BRCA1; BRCA2; Genetic screening germline mutation; Genomic rearrangements; Hereditary breast ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; MESSENGER RNA;

ARTICLE; BRCA2 GENE; BREAST CANCER; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE DELETION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE REARRANGEMENT; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; POPULATION DIFFERENTIATION; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE MULTIPLEX POLYMERASE CHAIN REACTION OF SHORT FLUORESCENT FRAGMENTS;

ADULT; BREAST NEOPLASMS; DNA, NEOPLASM; EXONS; FEMALE; GENE REARRANGEMENT; GENES, BRCA1; GENOME, HUMAN; GREECE; HUMANS; OVARIAN NEOPLASMS; PEDIGREE; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 33846317838     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.09.021     Document Type: Article

References (43)

1. Hall J.M., Lee M.K., Newman B., et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250 4988 (1990) 1684-1689
2. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 5182 (1994) 66-71
3. Smith T.M., Lee M.K., Szabo C.I., et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6 11 (1996) 1029-1049
4. Deininger P.L., and Batzer M.A. Alu repeats and human disease. Mol Genet Metab 67 3 (1999) 183-193
5. Puget N., Torchard D., Serova-Sinilnikova O.M., et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 57 5 (1997) 828-831
6. Puget N., Gad S., Perrin-Vidoz L., et al. Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 70 4 (2002) 858-865
7. Montagna M., Palma M.D., Menin C., et al. Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families. Hum Mol Genet 12 9 (2003) 1055-1061
8. Swensen J., Hoffman M., Skolnick M.H., and Neuhausen S.L. Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 6 9 (1997) 1513-1517
9. Gad S., Bieche I., Barrois M., et al. Characterisation of a 161 kb deletion extending from the NBR1 to the BRCA1 genes in a French breast-ovarian cancer family. Hum Mutat 21 6 (2003) 654
10. Payne S.R., Newman B., and King M.C. Complex germline rearrangement of BRCA1 associated with breast and ovarian cancer. Genes Chromosomes Cancer 29 1 (2000) 58-62
11. Gad S., Aurias A., Puget N., et al. Color bar coding the BRCA1 gene on combed DNA: a useful strategy for detecting large gene rearrangements. Genes Chromosomes Cancer 31 1 (2001) 75-84
12. Hogervorst F.B., Nederlof P.M., Gille J.J., et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63 7 (2003) 1449-1453
13. Rohlfs E.M., Puget N., Graham M.L., et al. An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 28 3 (2000) 300-307
14. Puget N., Stoppa-Lyonnet D., Sinilnikova O.M., et al. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions. Cancer Res 59 2 (1999) 455-461
15. Gad S., Caux-Moncoutier V., Pages-Berhouet S., et al. Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families. Oncogene 21 44 (2002) 6841-6847
16. Gad S., Klinger M., Caux-Moncoutier V., et al. Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer families. J Med Genet 39 11 (2002) 817-821
17. Petrij-Bosch A., Peelen T., van Vliet M., et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17 3 (1997) 341-345
18. Puget N., Sinilnikova O.M., Stoppa-Lyonnet D., et al. An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation. Am J Hum Genet 64 1 (1999) 300-302
19. The BRCA1 Exon 13 Duplication Screening Group. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 2000;67(1):207-212.
20. Hofmann W., Wappenschmidt B., Berhane S., Schmutzler R., and Scherneck S. Detection of large rearrangements of exons 13 and 22 in the BRCA1 gene in German families. J Med Genet 39 7 (2002) E36
21. Hofmann W., Gorgens H., John A., et al. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method. Hum Mutat 22 1 (2003) 103-104
22. Gad S., Scheuner M.T., Pages-Berhouet S., et al. Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing. J Med Genet 38 6 (2001) 388-392
23. Tancredi M., Sensi E., Cipollini G., et al. Haplotype analysis of BRCA1 gene reveals a new gene rearrangement: characterization of a 19.9 KBP deletion. Eur J Hum Genet 12 9 (2004) 775-777
24. Casilli F., Di Rocco Z.C., Gad S., et al. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat 20 3 (2002) 218-226
25. Rohlfs E.M., Chung C.H., Yang Q., et al. In-frame deletions of BRCA1 may define critical functional domains. Hum Genet 107 4 (2000) 385-390
26. Montagna M., Santacatterina M., Torri A., et al. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene 18 28 (1999) 4160-4165
27. Carson N.G.C., Hunter A., Allanson J., and Aubry H. An in frame deletion of BRCA1 exon 20 in a family with early onset breast cancer and ovarian cancer. Am J Hum Genet 65 (1999) A1610
28. Belogianni I., Apessos A., Mihalatos M., et al. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer. BMC Cancer 4 (2004) 61
29. de la Hoya M., Gutierrez-Enriquez S., Velasco E., et al. Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer. Clin Chem 52 8 (2006) 1480-1485
30. Preisler-Adams S., Schonbuchner I., Fiebig B., Welling B., Dworniczak B., and Weber B.H. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet 168 1 (2006) 44-49
31. Agata S., Viel A., Puppa L.D., et al. Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations. Genes Chromosomes Cancer 45 9 (2006) 791-797
32. Ellis D, Patel Y, Yau SC, Hodgson SV, Abbs SJ. Low prevalence of BRCA1 exon rearrangements in familial and young sporadic breast cancer patients. Fam Cancer 2006.
33. Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 25 5 (2005) 415-422
34. Woodward A.M., Davis T.A., Silva A.G., Kirk J.A., and Leary J.A. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet 42 5 (2005) e31
35. Walsh T., Casadei S., Coats K.H., et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. Jama 295 12 (2006) 1379-1388
36. Konstantopoulou I., Kroupis C., Ladopoulou A., et al. BRCA1 mutation analysis in breast/ovarian cancer families from Greece. Hum Mutat 16 3 (2000) 272-273
37. Ladopoulou A., Kroupis C., Konstantopoulou I., et al. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett 185 1 (2002) 61-70
38. Ladopoulou A., Konstantopoulou I., Armaou S., et al. A change in the last base of BRCA1 exon 23, 5586G → A, results in abnormal RNA splicing. Cancer Genet Cytogenet 134 2 (2002) 175-177
39. Armakolas A., Ladopoulou A., Konstantopoulou I., et al. BRCA2 gene mutations in Greek patients with familial breast cancer. Hum Mutat 19 1 (2002) 81-82
40. Ford D., Easton D.F., Stratton M., et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62 3 (1998) 676-689
41. Pavlicek A., Noskov V.N., Kouprina N., Barrett J.C., Jurka J., and Larionov V. Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition. Hum Mol Genet 13 22 (2004) 2737-2751
42. Glover J.N., Williams R.S., and Lee M.S. Interactions between BRCT repeats and phosphoproteins: tangled up in two. Trends Biochem Sci 29 11 (2004) 579-585
43. Garuti R., Lelli N., Barozzini M., et al. Partial deletion of the gene encoding sterol 27-hydroxylase in a subject with cerebrotendinous xanthomatosis. J Lipid Res 37 3 (1996) 662-672